Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by robertshawon Dec 04, 2016 10:00pm
133 Views
Post# 25553188

RE:RE:RE:RE:RE:RE:RE:RE:RE:Any delays from this point forward and you

RE:RE:RE:RE:RE:RE:RE:RE:RE:Any delays from this point forward and you

LaserStock29 wrote: Well, I do concern myself with the SP.. but I hear ya

Nasdaq requirements

I think we qualify for the Nasdaq Capital where we can qualify with a $2 closing price

** To qualify under the closing price alternative, a company must have: (i) average annual revenues of $6 million for three years, or (ii) net tangible assets of $5 million, or (iii) net tangible assets of $2 million and a 3 year operating history, in addition to satisfying the other financial and liquidity requirements listed above.

Anyone can comment on this.. seems to me that we have at least assets of $2 million and operate longer than 3 years... So with these quick endpoints... sets up a nice rollercoaster possibility.

:-)

skier59 wrote: Seriously forget the SP....it will drive you crazy ! This is the type of stock that can go from 29 cents to $29 in a couple of days. Everything is in good hands and finally Roger can watch his dream team try and solve a great challenge. I'm serious, I doubt we will see any SP appreciation until wind gets out about the trials.....unless those darn lasers are starting to sell in the USA ? We all know the serious problem our society has with Opiods...killing us ! Get this system on Health Care program Insurance and watch how this division can grow, I believe in this science as well.





Love to see the up list to Nasdaq, so that the stupid management doesn't have to do dirty low PP again and again. I think to get up list ,we also need a MM to support the share price(say maybe $1.0 over ) for a long period of time .but the current situation is the basement boys ' chief boss (the potential MM )only has the interest to bring down the share price to new low , of course with the help of basement boys and TLT management 's idiot PP strategy.
Bullboard Posts